
    
      360 patients who are on dabigatran, apixaban and rivaroxaban based on the above inclusion and
      exclusion criteria will be recruited. After the informed consent, the patient will be needed
      for blood taking before and 2 hours after the medication (NOAC). The patient's demographic
      data and medical history will also be retreived from Central Medical Syetem too.
    
  